What goes unresearched remains misunderstood, and what remains misunderstood goes untreated.
Por décadas, a dor de milhões de mulheres brasileiras foi tratada como algo ordinário — um fardo silencioso, não um problema científico a ser resolvido. Em junho de 2026, o Ministério da Ciência, Tecnologia e Inovação e o Instituto Alana anunciaram R$60 milhões destinados à pesquisa sobre endometriose, dor pélvica e saúde menstrual, reconhecendo que o que não é investigado não pode ser curado. É um gesto tardio, mas significativo: o Estado voltando seu olhar — e seus recursos — para o sofrimento que sempre esteve lá.
- Entre 5% e 15% das mulheres em idade reprodutiva vivem com endometriose, muitas sem diagnóstico, enquanto a dor se torna crônica e o corpo aprende a sofrer.
- A ausência histórica de financiamento para essas condições deixou médicos sem ferramentas e pacientes sem respostas — um vazio científico com custo humano imenso.
- R$50 milhões do CNPq serão direcionados a projetos de pesquisa e inovação, enquanto R$10 milhões do Instituto Alana construirão uma rede nacional de centros especializados.
- O diagnóstico precoce é o ponto de virada: intervir antes que a inflamação se consolide pode impedir que sintomas manejáveis na adolescência se tornem um fardo vitalício.
- Os resultados das pesquisas deverão embasar políticas públicas robustas e melhorar o atendimento às mulheres dentro do SUS — transformando ciência em cuidado concreto.
Numa tarde de terça-feira em Brasília, o governo brasileiro e o Instituto Alana anunciaram algo que faltava há muito tempo na agenda científica do país: recursos sérios para entender por que milhões de mulheres sofrem. Sessenta milhões de reais foram comprometidos para pesquisas sobre endometriose, dor pélvica e saúde menstrual — condições que afetam uma em cada dez mulheres em idade reprodutiva.
A endometriose continua sendo um enigma. O tecido que normalmente reveste o útero cresce onde não deveria, desencadeando inflamação crônica e dor. As causas exatas permanecem desconhecidas, e essa lacuna tem consequências reais: mulheres esperam anos por um diagnóstico, a dor se normaliza e o corpo aprende a sofrer de forma permanente.
O financiamento se divide em duas frentes: R$50 milhões pelo CNPq para bolsas e projetos de inovação em saúde feminina, e R$10 milhões do Instituto Alana para criar uma rede nacional de centros de pesquisa especializados. A CEO Flavia Doria foi direta ao nomear o problema — o que não é pesquisado permanece incompreendido, e o que permanece incompreendido fica sem tratamento.
O diagnóstico precoce muda a trajetória. Ele permite intervenção antes que a inflamação se acumule e antes que sintomas manejáveis na adolescência se tornem um fardo crônico na vida adulta. A ministra Luciana Santos posicionou o investimento como a resposta do Estado a uma crise de saúde pública que vinha sendo ignorada em silêncio.
O que vem a seguir importa tanto quanto o anúncio. As pesquisas produzirão descobertas sobre causas, ferramentas diagnósticas e protocolos de tratamento — e essas descobertas deverão alimentar políticas públicas que melhorem o atendimento às mulheres no SUS. As perguntas que ficaram sem resposta por tanto tempo finalmente têm recursos para serem feitas.
In a Brasília conference room on a Tuesday afternoon, Brazil's government and a major research institute announced something that has been missing from the country's scientific agenda for far too long: serious money aimed at understanding why millions of women hurt. The Ministry of Science, Technology and Innovation and Instituto Alana committed sixty million reais to fund research into endometriosis, pelvic pain, and menstrual health—conditions that touch the lives of one in ten women of reproductive age, from teenagers to adults in their prime working years.
Endometriosis remains a puzzle. The tissue that normally lines the inside of the uterus somehow grows where it shouldn't—in the abdomen, on organs, in places where it triggers chronic inflammation and pain. Scientists have theories: genetic predisposition, hormonal imbalance, immune system dysfunction, the backward flow of menstrual blood into the abdominal cavity. But the root cause remains unknown. This gap in understanding has real consequences. Women suffer for years before diagnosis. Pain becomes normalized, then chronic. The body learns to hurt.
The funding breaks down into two streams. Fifty million reais will flow through the National Council for Scientific and Technological Development, channeled into research grants and innovation projects focused on women's health. Another ten million comes from Instituto Alana itself, earmarked to build a national network of specialized research centers dedicated to these conditions. The announcement came on June 9th, 2026, and it represents something Health Minister Alexandre Padilha framed as overdue: visibility for diseases that have long been invisible in Brazil's public health conversation.
Flavia Doria, the CEO of Instituto Alana, articulated the stakes plainly: what goes unresearched remains misunderstood, and what remains misunderstood goes untreated. Early diagnosis of endometriosis changes the trajectory. It allows doctors to intervene before inflammation accumulates, before pain hardens into something chronic, before a teenager's manageable symptoms become a woman's lifelong burden. The longer treatment is delayed, the higher the cost—not just in money, but in the body's own learned patterns of suffering.
The prevalence numbers are sobering. Between five and fifteen percent of women in their reproductive years carry this diagnosis, though many more likely suffer without knowing what's wrong. That's millions of Brazilians. Minister Luciana Santos positioned the investment as the state's answer to a public health crisis that has been quietly grinding away, largely unexamined. She called it a commitment to science as a tool for care, inclusion, and quality of life.
What comes next matters. These research projects will eventually produce findings—about causes, about better diagnostic tools, about treatment protocols. Those findings will feed into policy. The hope, as Padilha stated it, is that robust public health policy can be built on this foundation, and that women moving through Brazil's unified health system will receive better care. For now, the research begins. The questions that have gone unasked for so long finally have resources behind them.
Citas Notables
What is not researched is not understood. What is not understood is not treated.— Flavia Doria, CEO of Instituto Alana
The longer pain goes untreated, the higher the cost. The body learns to feel that pain. Over time, inflammation mechanisms accumulate. What was not cared for in adolescence can become chronic pain in adulthood.— Flavia Doria, CEO of Instituto Alana
La Conversación del Hearth Otra perspectiva de la historia
Why did it take until 2026 for Brazil to fund this kind of research at this scale?
Because endometriosis and pelvic pain have never been treated as urgent public health problems. They're women's problems, and women's pain has always been easier to dismiss or medicalize individually rather than investigate systematically.
What changes when you actually research something that's been invisible?
Everything. Right now, diagnosis takes years. Women bounce between doctors who don't know what they're looking at. Once you have research, you have evidence. Evidence becomes policy. Policy becomes training for doctors, better diagnostic tools, actual treatment protocols.
The CEO mentioned that pain becomes chronic if it's not treated early. How does that work biologically?
Inflammation accumulates. The nervous system learns the pain pattern. What started as a treatable condition becomes wired into the body's baseline. A teenager's manageable symptoms become a woman's permanent condition. That's why early intervention isn't just about comfort—it's about preventing lifelong disability.
Is this just about individual women, or is there an economic angle?
Both. Untreated endometriosis costs the health system more in the long run. But more than that, it costs women their productivity, their careers, their quality of life. When you treat it early, you're not just reducing pain—you're keeping women in school, in work, in their lives.
What does a national research network actually do?
It coordinates. It shares findings across institutions. It trains the next generation of researchers who actually understand these conditions. Right now, knowledge is scattered. A network makes it systematic.
Will this money actually reach women, or will it just sit in research labs?
That depends on what happens after the research. The findings have to become policy, and policy has to reach the SUS—Brazil's public health system. That's the real test.